Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.650
-0.040 (-2.37%)
At close: Nov 14, 2025, 4:00 PM EST
2.150
+0.500 (30.32%)
After-hours: Nov 14, 2025, 7:59 PM EST
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $70.88 million as of November 14, 2025. Its market cap has decreased by -51.60% in one year.
Market Cap
70.88M
Enterprise Value
-37.94M
1-Year Change
-51.60%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $70.88M, a decrease of -92.51%. That is a compound annual growth rate of -38.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 70.88M | 27.28% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
| Jun 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |